Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk M W Verheul

Showing results (21-30 of 228) with videos related to

Pageof 23
Sort By:
Cancers|September 3, 2016
Imaging in Colorectal Cancer: Progress and Challenges for the CliniciansEric Van Cutsem, Henk M W Verheul, Patrik Flamen, et al.
Journal of Cancer Survivorship : Research and Practice|March 18, 2026
The impact of exercise on tolerability of systemic treatment in metastatic colorectal cancer: A literature reviewLaurien M Buffart, Calvin G Brouwer, Marlou-Floor Kenkhuis, et al.
Medical Oncology (Northwood, London, England)|June 23, 2010
Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorinFamke L Schneiders, H Pieter van den Berg, Godefridus J Peters, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2015
Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trialsMaurice J D L van der Vorst, Elisabeth C W Neefjes, Inge R H M Konings, et al.
Cancer Research|September 5, 2006
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alphaDavid Z Qian, Sushant K Kachhap, Spencer J Collis, et al.
Oncology Letters|July 12, 2012
Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinomaJamal Oulad Hadj, Rogier DEN Braven, Corrine Tillier, et al.
The Oncologist|September 5, 2014
Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignanciesMariette Labots, Lisette M Schütte, Johannes C van der Mijn, et al.
BMC Cancer|February 3, 2019
Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatmentClaudia S E W Schuurhuizen, Annemarie M J Braamse, Inge R H M Konings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitorsHenk M W Verheul, Brenda Salumbides, Karen Van Erp, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 28, 2017
The influence of different muscle mass measurements on the diagnosis of cancer cachexiaSusanne Blauwhoff-Buskermolen, Jacqueline A E Langius, Annemarie Becker, et al.
Pageof 23

Showing results (21-30 of 228) with videos related to

Sort By:
Pageof 23
Cancers|September 3, 2016
Imaging in Colorectal Cancer: Progress and Challenges for the CliniciansEric Van Cutsem, Henk M W Verheul, Patrik Flamen, et al.
Journal of Cancer Survivorship : Research and Practice|March 18, 2026
The impact of exercise on tolerability of systemic treatment in metastatic colorectal cancer: A literature reviewLaurien M Buffart, Calvin G Brouwer, Marlou-Floor Kenkhuis, et al.
Medical Oncology (Northwood, London, England)|June 23, 2010
Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorinFamke L Schneiders, H Pieter van den Berg, Godefridus J Peters, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2015
Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trialsMaurice J D L van der Vorst, Elisabeth C W Neefjes, Inge R H M Konings, et al.
Cancer Research|September 5, 2006
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alphaDavid Z Qian, Sushant K Kachhap, Spencer J Collis, et al.
Oncology Letters|July 12, 2012
Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinomaJamal Oulad Hadj, Rogier DEN Braven, Corrine Tillier, et al.
The Oncologist|September 5, 2014
Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignanciesMariette Labots, Lisette M Schütte, Johannes C van der Mijn, et al.
BMC Cancer|February 3, 2019
Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatmentClaudia S E W Schuurhuizen, Annemarie M J Braamse, Inge R H M Konings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitorsHenk M W Verheul, Brenda Salumbides, Karen Van Erp, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 28, 2017
The influence of different muscle mass measurements on the diagnosis of cancer cachexiaSusanne Blauwhoff-Buskermolen, Jacqueline A E Langius, Annemarie Becker, et al.
Pageof 23